Deutsche Bank’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

Deutsche Bank’s Portfolio PRDS Stock Details PRDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-147	Closed	-$266	–	3903
2023 Q2	$266	Sell	147 -20,066	-99%	-$36.7K	﹤0.01%	3777
2023 Q1	$26.7K	Buy	20,213 +8,475	+72%	+$13.9K	﹤0.01%	3680
2022 Q4	$19.8K	Buy	11,738 +230	+2%	+$291	﹤0.01%	3777
2022 Q3	$21K	Sell	11,508 -1,889	-14%	-$5.63K	﹤0.01%	3765
2022 Q2	$41K	Buy	+13,397	New	+$81.8K	﹤0.01%	3817

Other funds holding PRDS

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Deutsche Bank's PRDS Position: Q3 2023 in Review

Deutsche Bank sold out of Pardes Biosciences, Inc. Common Stock (PRDS) in Q3 2023, closing a stake of 147 shares — an estimated $266 sold.

Deutsche Bank first reported a position in PRDS in Q2 2022 and held it in 5 quarters. The position peaked at $41K in Q2 2022. 1 fund tracked by Wall St. Rank holds PRDS as of Q3 2023.

Deutsche Bank reported no remaining Pardes Biosciences, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Deutsche Bank sold 147 Pardes Biosciences, Inc. Common Stock shares in Q3 2023, an estimated $266.
Deutsche Bank first reported a position in Pardes Biosciences, Inc. Common Stock in Q2 2022 and held it in 5 quarters.
Deutsche Bank's Pardes Biosciences, Inc. Common Stock position peaked at $41K in Q2 2022.
1 fund tracked by Wall St. Rank held Pardes Biosciences, Inc. Common Stock as of Q3 2023.

Based on Deutsche Bank's 13F filing for Q3 2023, filed 9 Nov 2023.